1. Home
  2. NCNA vs SNOA Comparison

NCNA vs SNOA Comparison

Compare NCNA & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NuCana plc

NCNA

NuCana plc

BUY

Current Price

$0.95

Market Cap

4.0M

Sector

Health Care

ML Signal

BUY

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

HOLD

Current Price

$1.17

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCNA
SNOA
Founded
1997
1999
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
6.1M
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
NCNA
SNOA
Price
$0.95
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 73.9K
37.9K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.26
EPS
★ N/A
N/A
Revenue
N/A
★ $19,529,000.00
Revenue This Year
N/A
$22.44
Revenue Next Year
N/A
$12.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.68
52 Week Low
$0.95
$0.85
52 Week High
$4.55
$4.06

Technical Indicators

Market Signals
Indicator
NCNA
SNOA
Relative Strength Index (RSI) 27.54 37.78
Support Level $0.95 $1.03
Resistance Level $1.40 $1.29
Average True Range (ATR) 0.06 0.06
MACD -0.01 -0.01
Stochastic Oscillator 5.96 15.79

Price Performance

Historical Comparison
NCNA
SNOA

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: